Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.
about
Microbial ureases: significance, regulation, and molecular characterizationBinding and killing of bacteria by bismuth subsalicylateCampylobacter pylori and gastroduodenal disease.Antimicrobial therapies for Helicobacter pylori infection in gnotobiotic piglets.Treatment after failure: the problem of "non-responders".In vitro and in vivo activities of HPi1, a selective antimicrobial against Helicobacter pylori.Campylobacter associated gastritis in patients with non-ulcer dyspepsia.Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.Retrospective study of Campylobacter-like organisms in patients undergoing partial gastrectomyThe prevalence of Campylobacter pylori gastritis among asymptomatic adults.Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37Helicobacter pylori and peptic ulcers: the present position.Pernicious anaemia and Campylobacter like organisms; is the gastric antrum resistant to colonisation?Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study.Helicobacter pylori and gastritis in patients with peptic ulcer and non-ulcer dyspepsia: ethnic differences in Singapore.Helicobacter pylori: bridging the credibility gapEvaluation of 13C-urea breath test in the detection of Helicobacter pylori and in monitoring the effect of tripotassium dicitratobismuthate in non-ulcer dyspepsia.Gastroduodenal mucosa in uraemia: endoscopic and histological correlation and prevalence of helicobacter-like organisms.Helicobacter pylori and gastric cancer: correlation with gastritis, intestinal metaplasia, and tumour histology.Campylobacter pylori in a sample of Finnish population: relations to morphology and functions of the gastric mucosaNon-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pyloriCampylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitratePatterns of colonisation of Campylobacter pylori in the oesophagus, stomach and duodenumDyspepsia: is a trial of therapy appropriate?Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review.Guinea pig model for antibiotic transport across gastric mucosa: inhibitory tissue concentrations of clindamycin against Helicobacter pylori (Campylobacter pylori) following two separate dose regimens.Eradication of Helicobacter mustelae from the ferret stomach: an animal model of Helicobacter (Campylobacter) pylori chemotherapyIn vitro selection of resistant Helicobacter pylori.In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.Eradication of Helicobacter pylori: therapies and clinical implications.Transient protein losing enteropathy associated with acute gastritis and campylobacter pylori.Campylobacter pylori gastritis: long term results of treatment with amoxycillinLocal gastric and serum amoxicillin concentrations after different oral application forms.Role of metronidazole resistance in therapy of Helicobacter pylori infections.The effect of eradication of Helicobacter pylori upon the duodenal ulcer recurrence--a 24 month follow-up study.Campylobacter pyloridis: a new organism to explain an old problem?Expression of HLA-DR antigen in different histological types of gastric polyp.Association of Helicobacter pylori with HLA-DR antigen expression in gastritis.Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis.Imprint cytology--a cheap, rapid and effective method for diagnosing Helicobacter pylori.
P2860
Q24594053-EC8D1A64-CA05-4627-9AC5-2FBF1A8D2D6BQ24669770-C20AD53B-8FB8-4ADE-A91C-18BAD0936AACQ30667514-F82D42DA-C0C2-4875-A081-395878D723ACQ33693852-1DCC3F50-6235-4424-BB58-745B44B2849BQ33717362-6259012B-B6E2-43C6-8641-954FFF04CC83Q33797973-3D6C8949-477F-4825-8B2E-7C4A5EBC075CQ33838583-504B89DA-BCA1-4C4D-A0D9-65C7FCDB591CQ33838835-C5D0ECDE-55C5-4ED9-903A-528ED1B3082CQ33839701-B17905C4-60E7-4AC5-8CDB-2DB1602608B3Q34104614-75923AFA-8C05-4833-8D22-2E361C46EC72Q34175742-7618C941-C38C-4B21-BD8D-07CF20F744BCQ34375061-3EC11AA9-3D7E-495E-9F6A-308D4CAB3D8EQ34391331-5E99FFE1-282A-4858-B412-DD84530C5FB7Q34392083-369C49BD-92CF-4AFE-9EDB-4EA528E354AFQ34392680-F1C429F2-AEBE-4FA6-A704-E22988C1DD2AQ34392788-A93B2443-8BA0-4CB0-9947-3DBB6FBD01E7Q34393012-258A4F1A-EDD7-4F05-B2E4-5D397E2CF4CAQ34393165-D083B87A-F416-4214-AFAB-0B2D6BD9200EQ34395888-5327B706-29AC-4277-82DE-ADB054D3C70FQ34530564-CD5F58A9-E816-46F8-9F67-C3BB9272BBAAQ34531425-91BDAF04-4E3A-442A-BF48-0A53F82C2A66Q34532392-93193E6B-1715-4930-8BF7-CCE33EE9E3EEQ34532820-A10A8822-8DF6-4C2F-91A4-9F6966A16227Q34709092-E3611E37-5F4D-46A5-BCAB-C4AAB2D48DA9Q35011223-1E44B535-F746-42EC-81E9-30FC4E3172E1Q35245350-82E5146C-360D-4B5A-AB5C-0FCDE6AC474EQ35262924-C49BEF9F-B964-4277-81E2-36BF3125414DQ35271542-2807FE18-20FD-4B20-B70E-C54C922E5B7FQ35352378-5D626A8C-EA96-4C7A-9176-7D0CEC823CADQ35531059-9AAC11D8-A033-4315-92DF-3C97EE3BB4D3Q35604195-31EB58C3-5EEC-4B88-A044-5B79E5D87F3CQ35624418-4602A5ED-271B-4102-9165-E3F126DCF448Q35817181-EBA6819E-1FC1-4AC2-836B-0DE2A534E47CQ35843554-53B065D8-1225-4268-9A83-A2E75A9E796CQ35939006-0AC632DD-E862-4812-ABAB-B6BF89C30FD9Q36721493-3E9E6D0F-71ED-45B0-BEA1-4F728F6E0214Q37111442-E3834B97-1232-4540-B6BC-F36AF5FA6329Q37119777-11F56502-1704-4EF4-8711-F82AF3BA7AC2Q37358570-0114F311-17F9-45E1-B29F-24CDD1189751Q38659670-F8F864EE-423D-4DDA-A65F-0582693634C0
P2860
Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.
description
1986 nî lūn-bûn
@nan
1986 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Campylobacter pyloridis and as ...... d erythromycin ethylsuccinate.
@ast
Campylobacter pyloridis and as ...... d erythromycin ethylsuccinate.
@en
Campylobacter pyloridis and as ...... d erythromycin ethylsuccinate.
@nl
type
label
Campylobacter pyloridis and as ...... d erythromycin ethylsuccinate.
@ast
Campylobacter pyloridis and as ...... d erythromycin ethylsuccinate.
@en
Campylobacter pyloridis and as ...... d erythromycin ethylsuccinate.
@nl
prefLabel
Campylobacter pyloridis and as ...... d erythromycin ethylsuccinate.
@ast
Campylobacter pyloridis and as ...... d erythromycin ethylsuccinate.
@en
Campylobacter pyloridis and as ...... d erythromycin ethylsuccinate.
@nl
P2093
P2860
P1433
P1476
Campylobacter pyloridis and as ...... d erythromycin ethylsuccinate.
@en
P2093
Donovan IA
McNulty CA
Melikian V
P2860
P304
P407
P577
1986-09-01T00:00:00Z